Edition:
United States

Dr.Reddy's Laboratories Ltd (REDY.BO)

REDY.BO on Bombay Stock Exchange

2,427.30INR
6:21am EDT
Change (% chg)

Rs-93.25 (-3.70%)
Prev Close
Rs2,520.55
Open
Rs2,520.00
Day's High
Rs2,520.00
Day's Low
Rs2,400.00
Volume
52,391
Avg. Vol
39,584
52-wk High
Rs3,689.00
52-wk Low
Rs2,400.00

REDY.BO

Chart for REDY.BO

About

Dr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines. The Company operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment includes manufacturing and marketing prescription and... (more)

Overall

Beta: 0.11
Market Cap(Mil.): Rs417,138.81
Shares Outstanding(Mil.): 165.74
Dividend: 20.00
Yield (%): 0.79

Financials

  REDY.BO Industry Sector
P/E (TTM): 32.43 14.35 17.42
EPS (TTM): 77.61 -- --
ROI: -- -7.29 -5.45
ROE: -- -6.80 -4.73

BRIEF-Dr.Reddy's Labs' audit of formulations Srikakulum plant Unit II completed with zero observations

* Says audit of formulations Srikakulum Plant unit II, Andhra Pradesh by US FDA, completed with zero observations. Source text - (http://bit.ly/2qnkt2M) Further company coverage:

8:32am EDT

BRIEF-Dr.Reddy's Laboratories says USFDA approved launch of doxorubicin hydrochloride liposome injection in U.S.

* Announces USFDA approval for launch of doxorubicin hydrochloride liposome injection in U.S. Market Source text - (http://bit.ly/2qQ6RC6) Further company coverage:

May 17 2017

BRIEF-India's Dr.Reddy's Laboratories March-qtr consol profit rises about three-fold

* Consensus forecast for March quarter consol profit was 4.27 billion rupees

May 12 2017

BRIEF-Dr. Reddy's Labs launches Ezetimibe and Simvastatin tablets in U.S. market

* Says launch of Ezetimibe and Simvastatin tablets in U.S. market Source text for Eikon: Further company coverage:

Apr 27 2017

BRIEF-Fresenius sees no change in relationship of Merck KGaA's unit with partner Dr Reddy's

* Fresenius ceo sturm says we've had a good q1 but will not provide details

Apr 25 2017

BRIEF-Dr.Reddy's Laboratories announces launch of progesterone capsules in the U.S.

* Dr.Reddy's Laboratories - announces the launch ofprogesterone capsules in the U.S. market". Source text: (http://bit.ly/2pLTt0P) Further company coverage:

Apr 21 2017

Judge tosses drug packaging case against Dr. Reddy's, pharmacies

Dr. Reddy's Laboratories Ltd and three pharmacy chains have won the dismissal of a whistleblower lawsuit accusing them of fraudulently seeking federal reimbursement for drugs that were distributed in packaging not tested for child safety.

Mar 28 2017

BRIEF-Dr. Reddy's Labs, Integra Lifesciences sign deal to market Duragen products in India

* Co, Integra Lifesciences enter agreement to market, distribute Duragen plus and suturable duragen dural regeneration in India

Mar 27 2017

BRIEF-Cytosorbents Corp enters into a partnership with Dr. Reddy's laboratories

* Have entered into a partnership with Dr. Reddy's laboratories ltd for South African market

Mar 16 2017

BRIEF-Dr.Reddy's Labs gets form 483 with 3 observations from USFDA for audit of Miryalaguda plant

* Says the audit of API manufacturing plant at Miryalaguda, by the US FDA, has been completed on February 21, 2017

Feb 21 2017

More From Around the Web

Earnings vs. Estimates